Medicare Coverage for Atrial Fibrillation: Drugs, Ablation & Watchman Device

Medicare coverage for atrial fibrillation touches nearly every part of the program — from the free EKG at your Annual Wellness Visit to a $30,000 Watchman device implant covered under Part A. If you or a spouse has AFib, understanding exactly what each part of Medicare pays for — and what you will owe out of pocket — can mean the difference between a manageable bill and a financial shock. This guide walks through every major AFib service, the drugs that control it, and the coverage decisions that matter most for seniors living with this condition.

What Is Atrial Fibrillation and Why Does It Matter for Medicare?

Atrial fibrillation is the most common serious heart arrhythmia in the United States, affecting an estimated 6 million Americans — and the risk rises sharply after age 65. In AFib, the upper chambers of the heart quiver instead of contracting in a coordinated rhythm, allowing blood to pool and form clots. Those clots can travel to the brain and cause stroke.

Because AFib primarily affects older adults, Medicare is the dominant payer for AFib care in the country. The condition drives significant costs across diagnostics, long-term medication management, procedures, and hospitalizations — all of which Medicare covers, with important caveats about cost-sharing that depend heavily on what supplemental coverage you carry.

Part B: Diagnosing Atrial Fibrillation

EKG and Annual Wellness Visit

A standard 12-lead electrocardiogram (EKG) is often the first test used to diagnose or confirm AFib. If your doctor orders an EKG as a diagnostic test during a regular office visit, you pay the standard Part B cost-sharing: the Part B deductible ($257 in 2025) if not yet met, then 20% coinsurance.

However, if an EKG is performed as part of your Annual Wellness Visit, it is covered at $0 out of pocket — no deductible, no coinsurance. This is one reason it is worth scheduling your free Annual Wellness Visit every year, especially if you have risk factors for heart disease. If a previously undetected AFib is caught at that visit, you have saved the diagnostic cost and potentially prevented a stroke.

See Medicare and Heart Disease for a broader look at how Part B covers cardiac diagnostics and follow-up care.

Holter Monitor and Cardiac Event Monitor

When an office EKG is inconclusive — as it often is in paroxysmal (intermittent) AFib — your doctor will order ambulatory cardiac monitoring. Medicare Part B covers both types:

• Holter monitor: A continuous recording device worn for 24 to 48 hours. Covered under Part B; you pay 20% coinsurance after the deductible.
• Cardiac event monitor (30-day monitor): Records only when triggered by symptoms or automatically detects arrhythmias. Medicare covers these for up to 30 days as an outpatient service. The device is typically provided by a monitoring company that bills Part B directly.

Cost to you without supplemental coverage: roughly 20% of the allowed charge, which typically runs $40–$120 depending on the device type and monitoring period.

Implantable Loop Recorder (ILR)

For patients with unexplained fainting or very infrequent suspected arrhythmias, an implantable loop recorder is a small device inserted just under the skin of the chest that monitors heart rhythm continuously for up to three years. Medicare covers the ILR both as a durable medical equipment (DME) item and the associated implantation procedure under Part B. You pay 20% coinsurance on both the device and the procedure.

ILR implantation is done as a minor outpatient procedure under local anesthesia. Facility and physician fees combined typically run $3,000–$5,000 before Medicare discount, leaving your 20% share at $600–$1,000 without supplemental coverage.

Echocardiogram

An echocardiogram assesses heart structure and function — essential information when managing AFib. Medicare Part B covers:

• Transthoracic echocardiogram (TTE): The standard external echo. Covered under Part B with 20% coinsurance.
• Transesophageal echocardiogram (TEE): A more detailed image obtained by passing a probe down the esophagus, often done before cardioversion to rule out clots in the left atrial appendage. Covered under Part B or Part A depending on whether it is performed in an outpatient or inpatient setting.

Electrophysiology Study

An electrophysiology (EP) study is an invasive cardiac catheterization procedure used to map the electrical pathways of the heart and identify the source of arrhythmias. It is often performed in the same session as catheter ablation (discussed below). When done as a standalone diagnostic test, it is covered under Part B in an outpatient setting. In an inpatient setting, it falls under Part A. You pay 20% Part B coinsurance or the applicable Part A deductible ($1,676 per benefit period in 2025), depending on the setting.

Part D: Medications for Atrial Fibrillation

Managing AFib usually requires at least one long-term medication — and often two or three. The cost landscape varies enormously depending on the drug class.

Rate Control Medications

Rate control drugs slow the heart rate to a manageable level without necessarily restoring normal rhythm. The most commonly prescribed are:

• Metoprolol succinate (Toprol XL generic): A beta-blocker, available as a cheap generic. Tier 1 on most Part D formularies. Typical cost: $4–$15/month with Part D.
• Diltiazem (Cardizem generic): A calcium channel blocker used for rate control. Also a cheap generic. Tier 1–2 on most formularies. Typical cost: $5–$20/month with Part D.
• Digoxin: An older drug used for rate control, particularly in patients with heart failure. Generic is inexpensive. Tier 1 on most formularies. Typical cost: $4–$10/month with Part D.

These rate control medications are among the least expensive drugs in the Medicare system. Most seniors pay very little out of pocket for them, even without extra low-income subsidy (LIS) assistance.

Rhythm Control Medications

Rhythm control drugs attempt to restore and maintain normal sinus rhythm. They carry more side effect risk and often cost more:

• Flecainide (Tambocor generic): Used in patients without structural heart disease. Available as a generic. Tier 1–2 on most Part D plans. Typical cost: $10–$40/month.
• Sotalol (Betapace generic): A beta-blocker with antiarrhythmic properties. Generic available. Tier 1–2. Typical cost: $10–$30/month.
• Amiodarone (Pacerone generic): One of the most effective antiarrhythmics, often used when others fail. Long half-life, requires careful monitoring. Generic is inexpensive — Tier 1–2. Typical cost: $10–$25/month.
• Dronedarone (Multaq): A branded medication that is a modified version of amiodarone with a better side-effect profile. There is no generic as of 2025. Multaq is typically Tier 3 or Tier 4 on Part D formularies. Without extra help, retail cost is around $300–$450/month; with Part D coverage, your copay is typically $40–$100/month depending on your plan’s tier structure.

For more on how Part D formularies and tiers work, see Medicare Part D Explained.

Anticoagulation: The High-Dollar Part of AFib Treatment

This is where AFib costs can escalate dramatically — and where the 2025 Medicare Part D changes make an enormous difference.

Why Most AFib Patients Need Anticoagulation

Doctors use the CHA₂DS₂-VASc score to assess stroke risk in AFib patients. The score assigns points for risk factors:

A score of 2 or higher in men (1 or higher in women) indicates that anticoagulation therapy is recommended. For most seniors with AFib, a score of 2 or above is the norm. Without anticoagulation, AFib increases stroke risk by approximately 5 times compared to the general population.

Warfarin: Cheap but Complex

Warfarin (Coumadin generic) has been the standard anticoagulant for decades. The generic is available for $4–$10/month — among the cheapest drugs in Medicare. However, warfarin requires regular INR blood tests to monitor its effect, dietary restrictions (consistent vitamin K intake), and many drug interactions. The blood monitoring visits add their own Part B costs.

Direct Oral Anticoagulants (DOACs): Effective but Expensive

DOACs have largely replaced warfarin because they require no routine monitoring and have fewer interactions. But they come with a significant price tag:

• Apixaban (Eliquis): The most commonly prescribed DOAC for AFib. Retail cost without insurance: $500–$600/month — over $6,000/year. Tier 3–4 on Part D formularies.
• Rivaroxaban (Xarelto): Similar retail pricing to Eliquis. Tier 3–4.
• Dabigatran (Pradaxa): Slightly lower retail cost, still $400–$500/month without coverage.
• Edoxaban (Savaysa): Least commonly prescribed of the four. Similar pricing.

None of these have FDA-approved generic equivalents as of 2025 (generic apixaban has had limited availability in certain markets but is not universally available through Part D formularies at this writing).

The 2025 Part D $2,000 Out-of-Pocket Cap

Beginning in 2025, Medicare Part D has a $2,000 annual out-of-pocket cap on covered drug costs. This is one of the most significant changes to Medicare drug coverage in the program’s history — and it is particularly valuable for AFib patients on DOACs.

Here is how it changes the math for an Eliquis patient:

Before 2025 (old catastrophic coverage structure): An AFib patient on Eliquis could face $3,000–$4,000 or more in annual Part D out-of-pocket costs after the deductible, initial coverage phase, and coverage gap (“donut hole”).

In 2025 with the $2,000 cap: No Part D beneficiary pays more than $2,000/year for covered drugs. Once you hit that threshold, your covered medications cost $0 for the rest of the year. For an AFib patient on Eliquis, this cap is almost certainly reached by spring — and then Eliquis is free for the remainder of the year.

Additionally, the Medicare Prescription Payment Plan (M3P) allows you to spread your out-of-pocket costs in monthly installments across the year rather than paying a large lump sum early in the year.

For seniors who were previously skipping or rationing DOACs because of cost, this cap is life-changing. If you were on warfarin primarily because you could not afford a DOAC, it is worth discussing the switch with your cardiologist now that Part D cost exposure is capped.

Cardioversion: Restoring Normal Rhythm

Electrical cardioversion is a procedure in which a controlled electric shock is delivered to the heart to restore normal sinus rhythm. It is typically performed in an outpatient hospital or ambulatory surgery setting under brief sedation.

Medicare Part B covers outpatient cardioversion. You pay:

• The Part B deductible ($257 in 2025) if not yet met
• 20% coinsurance on the facility and physician charges

Total allowed charges for cardioversion typically run $1,500–$3,000 at Medicare rates, putting your 20% share at roughly $300–$600 without supplemental coverage. If you have Medigap Plan G, this 20% is covered entirely by your supplement (see below).

Catheter Ablation for AFib

Catheter ablation — specifically pulmonary vein isolation (PVI) — is the most effective procedure for eliminating or reducing AFib episodes. A cardiologist threads catheters to the heart through the femoral vein and uses either radiofrequency energy or extreme cold (cryoablation) to electrically isolate the pulmonary veins, which are the most common source of AFib triggers.

What Medicare Covers

Medicare covers AFib ablation as a medically necessary procedure. Coverage falls under:

• Part B if performed in a hospital outpatient department or ambulatory surgical center (ASC) — most common setting
• Part A if the patient is formally admitted as an inpatient

The procedure typically takes 3–5 hours under general anesthesia or deep sedation. Most patients go home the same day or stay one night.

What It Costs

Facility fees for AFib ablation at Medicare rates typically run $15,000–$25,000 for the technical component, plus the physician fee. Your 20% Part B coinsurance on a $20,000 procedure is $4,000 — before reaching any out-of-pocket maximum, which does not exist in Original Medicare.

With Medigap Plan G: Your Part B coinsurance is covered by the supplement after the $257 annual Part B deductible. Your total out-of-pocket for a $20,000 ablation: $257. This is one of the most compelling financial arguments for Plan G in high-cost cardiac procedures. See Medigap Plans Compared for a full breakdown of Plan G benefits.

With Medicare Advantage: AFib ablation is typically covered, but many plans require prior authorization — meaning the plan must approve the procedure before it is performed or you may face a denied claim. PA requirements vary by plan, and denials for ablation are not uncommon. Some MA plans have required that patients fail multiple medications before approving ablation. If you are considering catheter ablation, check your specific plan’s prior authorization requirements and be prepared to work with your cardiologist on the appeals process if needed.

The Watchman Device: Left Atrial Appendage Occlusion

For AFib patients who cannot safely take anticoagulants long-term — because of high bleeding risk, a history of serious bleeding events, or intolerance — the Watchman FLX device offers an alternative to stroke prevention.

What It Does

The left atrial appendage (LAA) is a small pouch in the upper-left chamber of the heart where blood clots commonly form in AFib patients. The Watchman is a small plug-like device that is permanently inserted into the LAA, sealing it off so clots cannot escape into the bloodstream and reach the brain.

Medicare Coverage

Medicare covers the Watchman implant as an inpatient procedure under Part A. It is typically performed in a cardiac catheterization lab under general anesthesia, with a one- to two-night hospital stay.

Part A cost-sharing in 2025:

• Days 1–60 of a benefit period: $1,676 deductible (no daily coinsurance)
• Days 61–90: $419/day coinsurance
• Beyond day 90: lifetime reserve days apply

Most Watchman patients are discharged within one to two days, so the cost to you is the $1,676 inpatient deductible per benefit period, plus the physician fee (which may be billed under Part B at 20% coinsurance).

With Medigap Plan G: The inpatient deductible is covered. The Part B physician coinsurance is covered after the annual deductible. Total patient cost is typically just the $257 Part B deductible for the year.

Eligibility Criteria

Medicare and clinical guidelines require that Watchman candidates:

1. Have nonvalvular AFib
2. Are recommended for anticoagulation (CHA₂DS₂-VASc score ≥ 2)
3. Have a reason to seek non-pharmacologic alternatives to long-term anticoagulation (e.g., high bleeding risk)

The procedure is not for everyone with AFib — it is specifically for patients who need stroke prevention but cannot safely use blood thinners long-term.

Pacemakers and Cardiac Resynchronization Therapy

Some AFib patients develop bradycardia (dangerously slow heart rate), either from the AFib itself or as a side effect of rate control medications. Others develop heart failure with reduced ejection fraction alongside their AFib.

Medicare covers pacemaker implantation and cardiac resynchronization therapy (CRT) devices under Part A for inpatient procedures and Part B for the associated outpatient components. Cost-sharing follows the same rules as other inpatient or outpatient procedures.

Hospital Stays for AFib Under Part A

AFib is a common reason for hospitalization — whether for a new diagnosis, a procedure, uncontrolled rapid rate, or stroke workup.

The 2-Midnight Rule

Medicare’s 2-midnight rule determines whether a hospital stay is covered as a full inpatient admission (Part A) or as observation status (outpatient, billed under Part B). The rule states: if the treating physician expects a hospital stay to require two or more midnights of medically necessary care, the patient should be admitted as an inpatient.

This distinction matters enormously. Under Part A inpatient status, you pay the $1,676 deductible once per benefit period (with no daily charges for the first 60 days). Under observation status (outpatient), you pay 20% Part B coinsurance on each service — and potentially much more if you end up staying several days.

If you are admitted for AFib and the stay is expected to be short — a single overnight for cardioversion, for example — you may be placed on observation status. Ask your care team explicitly: “Am I admitted as an inpatient or am I under observation?” The answer directly affects your bill.

For more detail on how Part A and stroke-related hospitalizations interact, see Medicare Coverage for Stroke and TIA.

Medigap vs. Medicare Advantage for AFib Patients

Your supplemental coverage choice may be the single most important financial decision you make as an AFib patient.

Why Medigap Plan G Is Particularly Valuable for AFib

Medigap Plan G covers:

• The Part A inpatient deductible ($1,676 per benefit period)
• Part B 20% coinsurance — including on all outpatient procedures, diagnostics, and physician services
• Part B excess charges (in states where providers can bill above Medicare rates)

For an AFib patient who might undergo cardioversion, ablation, echocardiograms, EP studies, or a Watchman implant in a single year, Plan G essentially transforms unpredictable large bills into a single, flat, predictable annual cost (the Plan G premium plus the $257 Part B deductible).

Example cost scenario — cardioversion plus echocardiogram in one year:

For catheter ablation alone, Plan G can save a patient $4,000 or more in a single year.

Medicare Advantage: Lower Premiums, More Risk for AFib Patients

Medicare Advantage vs. Original Medicare plans often advertise $0 premiums and added benefits. For generally healthy seniors, the math can work out. For AFib patients, the risks are more significant:

1. Prior authorization for ablation and Watchman: MA plans routinely require PA for high-cost cardiac procedures. Denials and appeals delays can disrupt care.
2. Network restrictions: Your preferred cardiologist or electrophysiologist may not be in-network.
3. Variable cost-sharing: Some MA plans have low copays for common services but high cost-sharing for hospital stays and procedures.
4. Out-of-pocket maximums: MA plans do have annual out-of-pocket maximums (up to $8,850 in 2025 for in-network care), which is a protection Original Medicare lacks — but Medigap Plan G accomplishes the same protection in a more predictable way for high-cost conditions.

See Medicare Supplement vs. Advantage Costs for a head-to-head cost comparison approach.

Real-Cost Scenarios for AFib Patients in 2025

Scenario 1: AFib Patient With Original Medicare Only (No Supplement)

A 72-year-old man with AFib on Eliquis and metoprolol, who has one cardioversion and two echocardiograms during the year:

• Part B deductible: $257
• Eliquis (Part D, hits $2,000 cap by March): $2,000
• Cardioversion (20% of $2,200): $440
• Two echocardiograms (20% of $1,200 combined): $240
• Cardiologist visits x6 (20% of ~$1,200): $240

Estimated total out-of-pocket: ~$3,177

If this patient needed catheter ablation instead of cardioversion, add roughly $4,000 more.

Scenario 2: Same Patient With Medigap Plan G

• Plan G premium (varies by age/state): ~$150/month = $1,800/year
• Part B deductible (not covered by Plan G): $257
• Eliquis (Part D cap still applies): $2,000
• All Part B coinsurance: $0

Estimated total out-of-pocket: ~$4,057 — slightly higher in a light year, but dramatically lower if a procedure like ablation occurs.

If ablation is needed this year: without Plan G, add ~$4,000; with Plan G, add $0.

Scenario 3: AFib Patient on Medicare Advantage

Results vary by plan. Assume a $0-premium PPO with $30 specialist copays, $350/day hospital coinsurance (days 1–5), and prior authorization required for ablation:

• Eliquis (Part D cap applies): $2,000
• Cardiologist visits x6: $180
• Cardioversion (hospital outpatient copay): $200–$400 (plan-specific)
• If ablation is approved: hospital coinsurance $350 x 1 day = $350 + physician copay

Apparent total: may look similar to Plan G in a straightforward year — but if an ablation is denied or delayed, the hidden cost is in delayed care, not just dollars. And if a multi-day hospital stay occurs, costs can escalate quickly.

Key Takeaways for Seniors With Atrial Fibrillation

1. Get your free Annual Wellness Visit — the $0 EKG could detect AFib before a stroke does.
2. Know your CHA₂DS₂-VASc score — most seniors with AFib need anticoagulation, and the 2025 Part D $2,000 cap makes DOACs like Eliquis far more affordable than they once were.
3. Ask about your admission status during any AFib hospitalization — inpatient vs. observation affects your bill significantly.
4. If you are considering ablation or a Watchman device, Medigap Plan G provides the most financial protection against the 20% coinsurance on high-cost cardiac procedures.
5. If you are on Medicare Advantage, verify prior authorization requirements for any cardiac procedure before scheduling it.

Atrial fibrillation is manageable with the right care — and understanding how Medicare covers that care is essential to making the best treatment and coverage decisions for your health and your wallet.